US2003036654A1PendingUtilityA1
Synthetic multimerizing agents
Priority: Aug 18, 1994Filed: Feb 28, 2002Published: Feb 20, 2003
Est. expiryAug 18, 2014(expired)· nominal 20-yr term from priority
C07D 401/14C07D 211/60C07D 401/12C07D 405/12C07D 207/16
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
New compounds are disclosed for multimerizing immunophilins and proteins containing immunophilin or immunophilin-related domains. The compounds are of the formula M—L—Q where M is a synthetic ligand for an FKBP protein
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A compound of the formula I:
M—L—Q I
a resolved stereoisomer thereof or mixture of one or more such stereoisomers, and pharmaceutically acceptable salts thereof, wherein
M is an immunophilinbinding group comprising a moiety of the formula II:
G is independently selected from the group consisting of:
Q comprises a moiety of formula II, a naturally occurring macrocyclic FKBP ligand or derivative thereof, or is a synthetic FKBP ligand of formula III:
n=1 or 2;
X=O, NH or CH 2 ;
B 1 and B 2 are independently H or aliphatic, heteroaliphatic, aryl or heteroaryl;
Y=O, S, NH, —NH(C═O)—, —NH(C═O)—O—, —NH(SO 2 )— or NR 3 , or represents a covalent bond from R 2 to carbon 9;
R 1 , R 2 , and R 3 are the same or different and are independently aliphatic, heteroaliphatic, aryl or heteroaryl; and,
L is a linker moiety covalently linking monomers M to Q or covalently linking M 1 to M 2 through covalent bonds to either R 1 or R 2 , not necessarily the same in each of M 1 and M 2 .Join the waitlist — get patent alerts
Track US2003036654A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.